BDP-8900

N/A

Report date: 2023/09/20 11:24:45

NME

Base Information

Drug NameBDP-8900

Drug Alias NameBDP-8900

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMyotonic dystrophy-related Cdc42-binding kinase MRCK inhibitors

TargetsMyotonic dystrophy-related Cdc42-binding kinase MRCK

Therapy Area/IndicationsSkin Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCancer Research UK

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSkin Neoplasms

Inactive IndicationsN/A

ATC CodeN/A